Activist Attack Puts Focus on Procter & Gamble Cost Cutting -- Update
By Sharon Terlep
Over the years when Procter & Gamble Co. wasn't able to sell more Tide or Pampers, the company could at least point to one clear success: a sweeping, $10 billion cost-cutting plan executed ahead of schedule.
Now that victory is murky.
Activist investor Nelson Peltz on Monday said he would seek a single board seat in a shareholder vote at the company's annual meeting, making P&G the largest company to ever face a proxy fight.
Mr. Peltz's Trian Management Fund argues that P&G failed to capitalize on a five-year savings plan that shrank the company by tens of thousands of employees, more than a dozen factories and hundreds of brands. Trian casts doubt on whether a second, five-year, $10-billion savings plan announced by P&G last year will produce results.
On Monday, P&G began mounting its defense, first pointing to a series of metrics outlining the company's improved profit margin, leaner structure and healthy cash generation.
"Over the past two years, P&G has accomplished the most significant portfolio transformation in its history," the company said. "Today, P&G is a leaner, more agile, more accountable and more efficient organization."
The company also criticized Trian, arguing the hedge fund "has not provided any new or actionable ideas to drive additional value for P&G shareholders beyond the continued successful execution of the strategic plan that is in place."
Trian, in meetings with P&G CEO David Taylor and other managers, offered no specific suggestions on how the company could better optimize cost savings, and was generally complimentary, according to people familiar with the situation. P&G ultimately saw no value in adding Mr. Peltz to the board, they said.
The activist isn't saying explicitly it wants more costs cut than the $10 billion P&G has targeted, and isn't giving specifics on how it would tackle the costs. But Trian is concerned about whether the goal will be hit.
Trian says years of P&G's underperformance in revenue and the stock market have raised questions about why the board should be given another year to execute without Mr. Peltz in the boardroom.
Central to Trian's case is the fate of roughly $3 billion of the $10 billion in P&G's previous cost reductions. P&G said the other $7 billion in savings were lost to currency fluctuations, which Trian doesn't dispute.
Trian argues, however, that if P&G were operating efficiently, the $3 billion would have shown up in increased sales and profit growth, both of which have been stalled for years.
Trian is concerned the latest cost-cutting initiative "could be as ineffective as the 2012 productivity program in driving sales growth, earnings growth and shareholder creation," Trian said in a regulatory filing Monday.
P&G shares were little changed Monday, rising less than 1% to $87.67 in afternoon trading. The stock has gained 2% in the last 12 months, compared with a 14% return in the S&P 500.
Gary Bradshaw, a fund manager at Hodges Fund, said he would support Mr. Peltz for the board. "I don't know he can change things overnight but, now, earnings aren't growing and that's what will eventually push the stock higher," said Mr. Bradshaw, whose fund has about 150,000 P&G shares.
--David Benoit contributed to this article.
Write to Sharon Terlep at email@example.com